(CNN) -- The Supreme Court said Wednesday that HHS failed to follow the proper procedures in varying reimbursement rates in a drug program aimed at hospitals that typically serve larger shares of disadvantaged patients.
The FDA on Monday approved a new treatment for alopecia areata, a condition that causes hair loss and affects more than 300,000 people a year in the U.S.
Seventeen drug companies, including some of the world's largest, are flouting a 30-year-old federal program that supports hospitals serving patients with low incomes and those who live in rural communities.
The FDA says that Pfizer's COVID-19 vaccine appears to be safe for children under 5 years old, the only age group not yet eligible for vaccination in the U.S.
Sanofi SNY, -2.06% said Monday that preliminary data shows that its experimental next-generation COVID-19 booster provided a 40-fold increase in antibody protection against BA.1, a subvariant of omicron, in adults who had been previously vaccinated with the mRNA shots.